Testosterone Prescribing In US Declined From 2013 Through 2016, Report Indicates.

reports that the “decline coincided with the publication of two articles linking testosterone therapy with stroke and myocardial infarction...which prompted the US Food and Drug Administration (FDA) to issue a safety communication and a requirement for a warning on the product label.” https://www.medpagetoday.com/urology/urology/73953